Find Real Relief
Are bladder or bowel control symptoms disrupting your life?1 You are not alone. Millions of people worldwide suffer from these life-altering symptoms.2
Axonics® Therapy is sacral neuromodulation for treating symptoms of:
Overactive Bladder
Bowel Incontinence
Urinary Retention
The Symptom Relief You Deserve.
Are you tired of the frequent bathroom trips or accidents? Axonics’ bladder and bowel therapy is a long-lasting and clinically proven treatment option that can help you restore normal function of your bladder and bowel.
Having Bladder and Bowel Control is Worth Celebrating!
Wendy – Celebrating 5 years of symptom relief!
“If anybody was thinking about doing this, I would tell them to go for it. It’s been an absolute life changer for me and my family. I can’t imagine life without Axonics.”
The Axonics Therapy Advantage
Try it out first
Discreet and disposable device that lets you experience first-hand if this therapy works for you
Long-lasting therapy
Clinically proven therapy that delivers long-lasting symptom relief
User-friendly
Simple device & tools for a user-friendly way to manage your therapy
Clinically Proven Results
of treated patients achieved clinically significant improvements at 2-year3
of patients were satisfied with their therapy3
Be Strengthened. Be Supported.
Want to connect with a real patient to learn about their story and
results with Axonics Therapy?
- Take the first step toward real relief:
Take this short quiz to get started and see whether Axonics Therapy may be right for you.
References:
1. Mayo Clinic website. https://www.mayoclinic.org/diseases-conditions/overactive-bladder/symptoms-causes/syc-20355715. Accessed June 10, 2019.
2. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132-1138.
3. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021;40(2):714-721. doi:10.1002/nau.24615
